Results 151 to 160 of about 30,220 (240)

Epidemiological and genetic characteristics of clinical carbapenemase-producing Enterobacterales isolates from Batna hospitals in Algeria

open access: yesBMC Infectious Diseases
Background Carbapenemase-producing Enterobacterales isolates are associated with significant mortality and have emerged as a major problem in healthcare settings worldwide.
Amel Benbouza   +6 more
doaj   +1 more source

Emergence of OXA-484, an OXA-48–type beta-lactamase, in Switzerland

open access: yesJournal of Global Antimicrobial Resistance, 2023
Jacqueline Findlay   +3 more
doaj   +1 more source

Emergence of OXA-48 Carbapenemase in Taiwan

open access: yesJournal of Microbiology, Immunology and Infection, 2015
Ma, Ling   +8 more
openaire   +1 more source

Activity of mecillinam against OXA-48-like carbapenemase-producing Enterobacterales

open access: yesJournal of Antimicrobial Chemotherapy, 2021
Tsakris, A.   +3 more
openaire   +3 more sources

Phage-meropenem synergy against OXA-48-producing Klebsiella pneumoniae clinical isolates. [PDF]

open access: yesNPJ Antimicrob Resist
Cantallops I   +6 more
europepmc   +1 more source

Carbapenem and colistin-resistant <i>Klebsiella pneumoniae</i> co-producing NDM-5 and OXA-48 in a teaching hospital from Tunisia. [PDF]

open access: yesJAC Antimicrob Resist
Jaidane N   +14 more
europepmc   +1 more source

Effects of phage-based treatments against an OXA-48-producing Klebsiella pneumoniae isolate in simulated human gut microbiomes. [PDF]

open access: yesBMC Microbiol
Ferriol-González C   +7 more
europepmc   +1 more source

Role of Giannella and Increment Scores to Predict OXA-48 Carbapenemase Producing Enterobacterales Infection and Mortality in Previous Rectal Carriers. [PDF]

open access: yesOpen Forum Infect Dis
Martínez Pérez-Crespo PM   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy